Form 13-F position report

ENTRADA THERAPEUTICS INC

Reported by CANTOR FITZGERALD L P

TRDA CUSIP 29384C108 Manager CIK 0001024896

Reported 60,000 shares, up 13,000 (27.7%) from the prior quarter.

Reported value -25.5%; share count 27.7% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 60,000 Quarter-end amount reported
Reported value $441,600 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-09-30 3905372
2025-12-31 585960
2026-03-31 593140
2026-06-30 441600
2026-09-30 381000

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for ENTRADA THERAPEUTICS INC held by CANTOR FITZGERALD L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 60,000 0 (0.0%) < 0.01% $381,000 2026-11-16
Q2 2026 Added 60,000 +13,000 (27.7%) < 0.01% $441,600 2026-08-14
Q1 2026 Reduced 47,000 -10,000 (-17.5%) < 0.01% $593,140 2026-05-15
Q4 2025 Reduced 57,000 -10,334 (-15.3%) < 0.01% $585,960 2026-02-17
Q3 2025 New 67,334 +67,334 (0.0%) 0.04% $3,905,372 2025-11-14

Who else reported the position

144 managers reported ENTRADA THERAPEUTICS INC for Q2 2026.

Managers reporting ENTRADA THERAPEUTICS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BAKER BROS ADVISORS LP Unchanged 5,072,730 0 0.19% $37,335,293 19 qtrs
5AM Venture Management LLC Unchanged 4,056,379 0 10.37% $29,854,949 19 qtrs
BlackRock Inc Added 2,583,333 +224,540 < 0.01% $19,013,332 8 qtrs
Merck & Co Inc New 1,739,768 +1,739,768 2.43% $12,804,692 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC Added 1,269,634 +13,621 < 0.01% $9,344,506 2 qtrs
BIOIMPACT CAPITAL LLC New 1,253,053 +1,253,053 0.56% $9,222,470 1 qtr
TCG Crossover Management LLC Reduced 1,060,230 -1,227,270 0.19% $7,803,293 19 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 954,419 -80,363 < 0.01% $7,024,524 19 qtrs
MILLENNIUM MANAGEMENT LLC Added 763,959 +244,603 < 0.01% $5,622,738 19 qtrs
StepStone Group LP Unchanged 761,277 0 0.26% $5,602,999 19 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 14, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
60,000
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.